Corvus Pharmaceuticals Inc buy Mizuho
Start price
20.05.25
/
50%
€3.27
Target price
20.05.26
€9.79
Performance (%)
136.14%
Price
08.12.25
€7.48
Summary
This prediction is currently active. The BUY prediction by Mizuho for Corvus Pharmaceuticals Inc has seen massive gains of 136.14%. This prediction currently runs until 20.05.26. The prediction end date can be changed by Mizuho at any time. Mizuho has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Corvus Pharmaceuticals Inc | -2.975% | -2.975% |
| iShares Core DAX® | 1.917% | 1.088% |
| iShares Nasdaq 100 | 0.911% | 1.674% |
| iShares Nikkei 225® | 0.833% | -1.712% |
| iShares S&P 500 | 0.242% | 1.258% |
Comments by Mizuho for this prediction
In the thread Corvus Pharmaceuticals Inc diskutieren
Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS) had its price target lowered by analysts at Mizuho from $12.00 to $11.00. They now have an "outperform" rating on the stock.
Ratings data for CRVS provided by MarketBeat